Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study.

Bjørge, Tone; Hjellvik, Vidar; Bjørge, Line; Dos-Santos-Silva, Isabel; Furu, Kari; Kvåle, Rune; Engeland, Anders

Bjørge, Tone; Hjellvik, Vidar; Bjørge, Line; Dos-Santos-Silva, Isabel; Furu, Kari; Kvåle, Rune; Engeland, Anders.

Affiliation

Bjørge T; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Hjellvik V; Cancer Registry of Norway, Oslo, Norway.
Bjørge L; Norwegian Institute of Public Health, Bergen/Oslo, Norway.
Dos-Santos-Silva I; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway.
Furu K; Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Kvåle R; Norwegian Institute of Public Health, Bergen/Oslo, Norway.
Engeland A; Norwegian Institute of Public Health, Bergen/Oslo, Norway.

BJOG ; 130(7): 770-778, 2023 06.

Article de En | MEDLINE | ID: mdl-36700296

Sujet(s)
Mots clés

cervical cancer; chronic diseases; drugs; medication; ovarian cancer; pharmacoepidemiology; population-based; uterine corpus cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs de l'utérus / Tumeurs de l'appareil génital féminin Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Female / Humans / Middle aged Langue: En Journal: BJOG Sujet du journal: GINECOLOGIA / OBSTETRICIA Année: 2023 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google